Found 0 matching trials
A Trial to Evaluate Tolerability and Immunogenicity of V540D in Healthy Adults (V540D-004) PHASE1 Researchers are looking for new ways to prevent cancers related to human pa...
Show More Status
Active Not Recruiting
Location
Research Centers of America ( Hollywood ) ( Site 0001)
Learn More & Join Trial
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil® PHASE3 The aim of the study was to assess the safety and immunogenicity of the CYD...
Show More Location
Sanofi Pasteur Investigational Site 004
Learn More & Join Trial
Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts PHASE3 Cutaneous viral warts are very common and are caused by the human papilloma...
Show More Learn More & Join Trial
A Phase II Study of SCT1000 in Healthy Women Aged 18 to 45 Years PHASE2 A phase II random, double blind, positive and placebo control trail was con...
Show More Location
Guanyun Country CDC
Learn More & Join Trial
An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED) PHASE3 This is a China registration study. A randomized, double-blind, placebo-con...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy of Lentinula Edodes-Derived Supplement (AHCC®) in Promoting Negativity of Persistent HPV Infection N/A This is a retrospective, multicenter, observational study evaluating real-w...
Show More Location
University of Insubria
Learn More & Join Trial
Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial PHASE3 This phase IIIb trial compares a single dose of the Cervarix vaccine in gir...
Show More Location
Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Learn More & Join Trial
A Clinical Study of V503 in Chinese Females Who Have Previously Received a Bivalent Human Papillomavirus (HPV) Vaccine (V503-108) PHASE3 Researchers want to learn if V503 (also called the 9-valent human papilloma...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV. PHASE4 The Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection...
Show More Status
Active Not Recruiting
Location
Botswana Harvard Health Partnership
Learn More & Join Trial
Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients PHASE3 Patients with immunodeficiencies are at increased risk of developing persis...
Show More Learn More & Join Trial